AAAAAA

   
Results: 1-4 |
Results: 4

Authors: ROLLINS SA FITCH JCK SHERNAN S RINDER CS RINDER HM SMITH BR COLLARD CD STAHL GL ALFORD BL LI L MATIS LA
Citation: Sa. Rollins et al., ANTI-C5 SINGLE-CHAIN ANTIBODY THERAPY BLOCKS COMPLEMENT AND LEUKOCYTEACTIVATION AND REDUCES MYOCARDIAL TISSUE-DAMAGE IN CPB PATIENTS, Molecular immunology, 35(6-7), 1998, pp. 266-266

Authors: FITCH JCK ELEFTERIADES JA MATIS LA EVANS MJ RINDER HM ROLLINS SA ALFORD BL HINES RL
Citation: Jck. Fitch et al., SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS, Journal of the American College of Cardiology, 29(2), 1997, pp. 28169-28169

Authors: ALFORD BL SHERRELL DL
Citation: Bl. Alford et Dl. Sherrell, THE ROLE OF AFFECT IN CONSUMER SATISFACTION JUDGMENTS OF CREDENCE-BASED SERVICES, Journal of business research, 37(1), 1996, pp. 71-84

Authors: FITCH JCK ELEFTERIADES JA RINDER JM MATIS LA EVANS MJ ROLLINS SA ALFORD BL HINES RL
Citation: Jck. Fitch et al., SAFETY, PHARMACOKINETICS, AND IMMUNOGENICITY OF INTRAVENOUS ADMINISTRATION OF H5G1.1-SCFV IN HUMANS, Blood, 88(10), 1996, pp. 2603-2603
Risultati: 1-4 |